PS1Nicastrin Interaction and Role in Trafficking
About the Research Project
Program
Award Type
Standard
Award Amount
$199,939
Active Dates
April 01, 2001 - March 31, 2003
Grant ID
A2001074
Summary
It is well known that presenilin proteins (PS-1 and PS-2) and other proteins interact to generate amyloid beta protein. Recently, researchers at the University of Toronto (with whom Dr. Thinakaran is collaborating) identified one of the proteins, Nicastrin, that interacts with presenilins. A better understanding of the association between presenilins and Nicastrin will shed more light on the mechanisms involved in amyloid beta production, and perhaps lead to new therapies for AD aimed at reducing amyloid beta deposits in the brain. Some studies also indicate that presenilins may be involved in assisting APP (the precursor for amyloid beta) in reaching appropriate destinations within the cell. Dr. Thinakaran is examining whether presenilins direct other proteins to their destinations. He will explore this issue by studying two proteins that resemble APP and others that have structures different from that of APP. It is hoped that these latter studies will help scientists understand what presenilins normally do. The information gained from studies like this will be critical to determining whether presenilins can be considered as appropriate targets for the treatment of AD.
Related Grants
Alzheimer's Disease Research
Progranulin as a Potential Therapeutic Target for Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Andrew Nguyen, PhD
Current Organization
Saint Louis University
Progranulin as a Potential Therapeutic Target for Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Andrew Nguyen, PhD
Current Organization
Saint Louis University
Alzheimer's Disease Research
Does Alzheimer’s Disease Accelerate Brain Aging?
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
MaríA Llorens-Martín, PhD
Current Organization
Spanish National Research Council
Does Alzheimer’s Disease Accelerate Brain Aging?
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
MaríA Llorens-Martín, PhD
Current Organization
Spanish National Research Council
Alzheimer's Disease Research
Mechanisms of Inhibitory Neuron Vulnerability to Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Emiliano Zamponi, PhD
Current Organization
Columbia University
Mechanisms of Inhibitory Neuron Vulnerability to Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Emiliano Zamponi, PhD
Current Organization
Columbia University